The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.

[1]  H. Schuitemaker,et al.  Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control , 2011, AIDS.

[2]  H. Schuitemaker,et al.  Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS. , 2011, The Journal of infectious diseases.

[3]  E. Bunnik,et al.  Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies , 2011, Journal of Virology.

[4]  N. Brieu,et al.  Interleukin-7 induces HIV type 1 R5-to-X4 switch. , 2011, Blood.

[5]  A. Telenti,et al.  Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load , 2010, PLoS pathogens.

[6]  E. Bunnik,et al.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.

[7]  H. Schuitemaker,et al.  Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  E. Bunnik,et al.  Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. , 2010, The Journal of infectious diseases.

[9]  Terri Wrin,et al.  Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors , 2010, Journal of Virology.

[10]  Ard van Sighem,et al.  Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands , 2009, PloS one.

[11]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[12]  M. Suchard,et al.  Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. , 2008, Molecular biology and evolution.

[13]  Hanneke Schuitemaker,et al.  Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.

[14]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[15]  B. Korber,et al.  Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing , 2008, Journal of Virology.

[16]  D. Huson,et al.  Dendroscope: An interactive viewer for large phylogenetic trees , 2007, BMC Bioinformatics.

[17]  Andrew J. Low,et al.  Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates , 2007, Antiviral therapy.

[18]  Jun Zhang,et al.  Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities. , 2007, Antiviral research.

[19]  J. Overbaugh,et al.  Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.

[20]  S. Ho,et al.  Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.

[21]  J. Albert,et al.  Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. , 2005, The Journal of general virology.

[22]  L. Stamatatos,et al.  The V1, V2, and V3 Regions of the Human Immunodeficiency Virus Type 1 Envelope Differentially Affect the Viral Phenotype in an Isolate-Dependent Manner , 2005, Journal of Virology.

[23]  Martin Fisher,et al.  Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections , 2005, AIDS.

[24]  Bette Korber,et al.  Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. , 2004, Glycobiology.

[25]  Donald E. Mosier,et al.  Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching , 2004, Journal of Virology.

[26]  Christopher D Pilcher,et al.  Brief but efficient: acute HIV infection and the sexual transmission of HIV. , 2004, The Journal of infectious diseases.

[27]  J. Margolick,et al.  Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences , 2003, Journal of Virology.

[28]  M. Suchard,et al.  Hierarchical phylogenetic models for analyzing multipartite sequence data. , 2003, Systematic biology.

[29]  H. Schuitemaker,et al.  Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. , 2003, The Journal of infectious diseases.

[30]  Maria Prins,et al.  Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution. , 2003, AIDS research and human retroviruses.

[31]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[32]  D. Swofford,et al.  Inferring Evolutionary Trees with PAUP* , 2003, Current protocols in bioinformatics.

[33]  T. Leitner,et al.  Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. , 2002, The Journal of infectious diseases.

[34]  J P Bru,et al.  Acute HIV infection: impact on the spread of HIV and transmission of drug resistance , 2001, AIDS.

[35]  R B Geskus,et al.  On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. , 2000, Statistics in medicine.

[36]  J. Albert,et al.  Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS. , 1999, Journal of human virology.

[37]  H. Schuitemaker,et al.  Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression. , 1999, The Journal of infectious diseases.

[38]  Y. Soda,et al.  Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. , 1999, Virology.

[39]  Amanda M. Brown,et al.  Selection for Neutralization Resistance of the Simian/Human Immunodeficiency Virus SHIVSF33A Variant In Vivo by Virtue of Sequence Changes in the Extracellular Envelope Glycoprotein That Modify N-Linked Glycosylation , 1999, Journal of Virology.

[40]  Pascal Poignard,et al.  Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants , 1999, Journal of Virology.

[41]  H. Schuitemaker,et al.  Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages. , 1999, Virology.

[42]  B. Leynaert,et al.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. , 1998, American journal of epidemiology.

[43]  Carla Kuiken,et al.  Evolution of Syncytium-Inducing and Non-Syncytium-Inducing Biological Virus Clones in Relation to Replication Kinetics during the Course of Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.

[44]  Z. Yang,et al.  Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. , 1998, Molecular biology and evolution.

[45]  J. Sodroski,et al.  Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein , 1997, Journal of virology.

[46]  E. Fenyö,et al.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression , 1997, Nature Medicine.

[47]  Ziheng Yang,et al.  PAML: a program package for phylogenetic analysis by maximum likelihood , 1997, Comput. Appl. Biosci..

[48]  H. Schuitemaker,et al.  Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV infection and prognostic value of SI phenotype for survival after aids diagnoses , 1997 .

[49]  S M Pollock,et al.  The role of early HIV infection in the spread of HIV through populations. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[50]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[51]  J. Albert,et al.  Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Chesebro,et al.  Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes , 1996, Journal of virology.

[53]  R. Doms,et al.  A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains , 1996, Journal of virology.

[54]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[55]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[56]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[57]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[58]  H. Schuitemaker,et al.  Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. , 1996, The Journal of infectious diseases.

[59]  C. Cheng‐Mayer,et al.  Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. , 1995, Virology.

[60]  D. Venzon,et al.  Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype. , 1995, The Journal of pediatrics.

[61]  I. Longini,et al.  Role of the primary infection in epidemics of HIV infection in gay cohorts. , 1995, Journal of acquired immune deficiency syndromes.

[62]  H. Schuitemaker,et al.  Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR , 1995, Journal of clinical microbiology.

[63]  J. Albert,et al.  MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. , 1994, The Journal of infectious diseases.

[64]  Kees,et al.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. , 1994, The Journal of clinical investigation.

[65]  N. Goldman,et al.  A codon-based model of nucleotide substitution for protein-coding DNA sequences. , 1994, Molecular biology and evolution.

[66]  J. Albert,et al.  MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection , 1994, Journal of clinical microbiology.

[67]  J. Albert,et al.  Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. , 1993, Virology.

[68]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[69]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[70]  C. Cheng‐Mayer,et al.  Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Kuiken,et al.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.

[72]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.

[73]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[74]  R. Coutinho,et al.  HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay , 1992, AIDS.

[75]  Michael Emerman,et al.  Single amino-acid changes in HIV envelope affect viral tropism and receptor binding , 1989, Nature.

[76]  G. Groen,et al.  Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag. , 1989, Virology.

[77]  P. Lemey,et al.  The Phylogenetic Handbook: List of contributors , 2009 .

[78]  Hanneke Schuitemaker,et al.  Isolation and propagation of HIV-1 on peripheral blood mononuclear cells , 2008, Nature Protocols.

[79]  Sergei L. Kosakovsky Pond,et al.  Estimating selection pressures on alignments of coding sequences Analyses using HyPhy , 2007 .

[80]  Graziano Pesole,et al.  BMC Evolutionary Biology BioMed Central , 2007 .

[81]  H. Kishino,et al.  Dating of the human-ape splitting by a molecular clock of mitochondrial DNA , 2005, Journal of Molecular Evolution.

[82]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[83]  H. Schuitemaker,et al.  Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. , 1999, The Journal of infectious diseases.

[84]  David Posada,et al.  MODELTEST: testing the model of DNA substitution , 1998, Bioinform..

[85]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[86]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[87]  Sergei L. Kosakovsky Pond,et al.  BIOINFORMATICS APPLICATIONS , 2022 .

[88]  B. Boeser-Nunnink,et al.  Uva-dare (digital Academic Repository) Increased in Vitro Cytopathicity of Cc Chemokine Receptor 5-restricted Human Immunodeficiency Virus Type 1 Primary Isolates Correlates with a Progressive Clinical Course of Infection , 2022 .